S. D. Rubin

Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain

Brunilde Gril, Dario Palmieri, Julie L. Bronder et al. · JNCI Journal of the National Cancer Institute · 2008 · 287 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

Harold J. Burstein, Anna Maria Storniolo, Sandra Franco et al. · Annals of Oncology · 2008 · 206 citations

Medicine, Oncology, Pharmacology +16

Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens

Kimberly Blackwell, Mark D. Pegram, Elizabeth Tan-Chiu et al. · Annals of Oncology · 2009 · 169 citations · Full text

Medicine, Oncology, Pharmacology +16

Developmental expression of the vav protooncogene.

Xosé R. Bustelo, S. D. Rubin, Ki‐Ling Suen et al. · PubMed · 1993 · 88 citations

Life Sciences, Developmental Biology, Molecular Biology +14

Evaluation of lapatinib (Lap) plus capecitabine (Cap) in patients with brain metastases (BM) from HER2+ breast cancer (BC) enrolled in the Lapatinib Expanded Access Program (LEAP) and French Authorisation Temporaire d'Utilisation (ATU)

Francesco Boccardo, Bella Kaufman, José Baselga et al. · Journal of Clinical Oncology · 2008 · 44 citations

Medicine, Oncology, Pharmacology +16